Satoru Kohgo

995 total citations
35 papers, 812 citations indexed

About

Satoru Kohgo is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Satoru Kohgo has authored 35 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 14 papers in Virology and 13 papers in Epidemiology. Recurrent topics in Satoru Kohgo's work include HIV/AIDS drug development and treatment (28 papers), HIV Research and Treatment (14 papers) and HIV/AIDS Research and Interventions (10 papers). Satoru Kohgo is often cited by papers focused on HIV/AIDS drug development and treatment (28 papers), HIV Research and Treatment (14 papers) and HIV/AIDS Research and Interventions (10 papers). Satoru Kohgo collaborates with scholars based in Japan, United States and Malaysia. Satoru Kohgo's co-authors include Hiroaki Mitsuya, Eiichi Kodama, Hiroshi Ohrui, Masao Matsuoka, Kenji Kitano, Hiroyuki Hayakawa, Noriyuki Ashida, Shirô Shigeta, Hirotomo Nakata and Stefan G. Sarafianos and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Hepatology.

In The Last Decade

Satoru Kohgo

35 papers receiving 799 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Satoru Kohgo Japan	15	620	434	279	245	161	35	812
A. McMillan United States	9	779 1.3×	528 1.2×	338 1.2×	315 1.3×	191 1.2×	10	1.0k
Maryam Ehteshami United States	17	513 0.8×	333 0.8×	259 0.9×	293 1.2×	83 0.5×	29	820
Takahiro Seki Japan	11	856 1.4×	739 1.7×	379 1.4×	147 0.6×	72 0.4×	18	952
Jőrg‐Peter Kleim United Kingdom	12	488 0.8×	433 1.0×	137 0.5×	82 0.3×	85 0.5×	17	849
Anne V. Broadhurst United Kingdom	6	591 1.0×	514 1.2×	302 1.1×	102 0.4×	216 1.3×	8	855
Shigeru Miki Japan	13	774 1.2×	733 1.7×	299 1.1×	124 0.5×	65 0.4×	20	879
Nilima Kutty United States	8	558 0.9×	391 0.9×	235 0.8×	200 0.8×	125 0.8×	10	681
Patrícia Recordon-Pinson France	19	685 1.1×	672 1.5×	167 0.6×	225 0.9×	59 0.4×	70	1.0k
Kenji Kitano Japan	11	425 0.7×	232 0.5×	279 1.0×	122 0.5×	264 1.6×	16	609
S. Galpin United Kingdom	14	828 1.3×	707 1.6×	365 1.3×	272 1.1×	211 1.3×	23	1.2k

Countries citing papers authored by Satoru Kohgo

Since Specialization

Citations

This map shows the geographic impact of Satoru Kohgo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoru Kohgo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoru Kohgo more than expected).

Fields of papers citing papers by Satoru Kohgo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoru Kohgo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoru Kohgo. The network helps show where Satoru Kohgo may publish in the future.

Co-authorship network of co-authors of Satoru Kohgo

This figure shows the co-authorship network connecting the top 25 collaborators of Satoru Kohgo. A scholar is included among the top collaborators of Satoru Kohgo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoru Kohgo. Satoru Kohgo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yasutake, Y., Shin-ichiro Hattori, Noriko Tamura, et al.. (2020). Structural features in common of HBV and HIV-1 resistance against chirally-distinct nucleoside analogues entecavir and lamivudine. Scientific Reports. 10(1). 3021–3021. 19 indexed citations

Higashi‐Kuwata, Nobuyo, Sanae Hayashi, Debananda Das, et al.. (2019). CMCdG, a Novel Nucleoside Analog with Favorable Safety Features, Exerts Potent Activity against Wild-Type and Entecavir-Resistant Hepatitis B Virus. Antimicrobial Agents and Chemotherapy. 63(4). 15 indexed citations

Kumamoto, Hiroki, Manabu Aoki, Masayuki Amano, et al.. (2019). Synthesis and evaluation of the anti-hepatitis B virus activity of 4′-Azido-thymidine analogs and 4′-Azido-2′-deoxy-5-methylcytidine analogs: structural insights for the development of a novel anti-HBV agent. Nucleosides Nucleotides & Nucleic Acids. 39(4). 518–529. 1 indexed citations

Yasutake, Y., Shin‐ichiro Hattori, Noriko Tamura, et al.. (2019). Active-site deformation in the structure of HIV-1 RT with HBV-associated septuple amino acid substitutions rationalizes the differential susceptibility of HIV-1 and HBV against 4ʹ-modified nucleoside RT inhibitors. Biochemical and Biophysical Research Communications. 509(4). 943–948. 8 indexed citations

Yasutake, Y., Shin-ichiro Hattori, Hironori Hayashi, et al.. (2018). HIV-1 with HBV-associated Q151M substitution in RT becomes highly susceptible to entecavir: structural insights into HBV-RT inhibition by entecavir. Scientific Reports. 8(1). 1624–1624. 16 indexed citations

Hashimoto, Mai, Kazuaki Taguchi, Satoru Kohgo, et al.. (2018). Pharmacokinetic properties of a novel inosine analog, 4′-cyano-2′-deoxyinosine, after oral administration in rats. PLoS ONE. 13(6). e0198636–e0198636. 2 indexed citations

Takamatsu, Yuki, Debananda Das, Satoru Kohgo, et al.. (2018). The High Genetic Barrier of EFdA/MK-8591 Stems from Strong Interactions with the Active Site of Drug-Resistant HIV-1 Reverse Transcriptase. Cell chemical biology. 25(10). 1268–1278.e3. 22 indexed citations

Takamatsu, Yuki, Yasuhito Tanaka, Satoru Kohgo, et al.. (2015). 4′‐modified nucleoside analogs: Potent inhibitors active against entecavir‐resistant hepatitis B virus. Hepatology. 62(4). 1024–1036. 40 indexed citations

Hattori, Shin-ichiro, Hirotomo Nakata, Hideki Harada, et al.. (2009). Potent Activity of a Nucleoside Reverse Transcriptase Inhibitor, 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine, against Human Immunodeficiency Virus Type 1 Infection in a Model Using Human Peripheral Blood Mononuclear Cell-Transplanted NOD/SCID Janus Kinase 3 Knockout Mice. Antimicrobial Agents and Chemotherapy. 53(9). 3887–3893. 43 indexed citations

10.

Nakata, Hirotomo, Masayuki Amano, Yasuhiro Koh, et al.. (2007). Activity against Human Immunodeficiency Virus Type 1, Intracellular Metabolism, and Effects on Human DNA Polymerases of 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine. Antimicrobial Agents and Chemotherapy. 51(8). 2701–2708. 84 indexed citations

11.

Ohrui, Hiroshi, Satoru Kohgo, Hiroyuki Hayakawa, et al.. (2007). 2′-Deoxy-4′-C-Ethynyl-2-Fluoroadenosine: A Nucleoside Reverse Transcriptase Inhibitor with Highly Potent Activity Against Wide Spectrum of HIV-1 Strains, Favorable Toxic Profiles, and Stability in Plasma. Nucleosides Nucleotides & Nucleic Acids. 26(10-12). 1543–1546. 42 indexed citations

12.

Ohrui, Hiroshi, Satoru Kohgo, Hiroyuki Hayakawa, et al.. (2006). 2′-Deoxy-4′-C-ethynyl-2-fluoroadenosine: A nucleoside reverse transcriptase inhibitor with highly potent activity against all HIV-1 strains, favorable toxic profiles and stability in plasma. Nucleic Acids Symposium Series. 50(1). 1–2. 14 indexed citations

13.

Ohrui, Hiroshi, Hiroyuki Hayakawa, Satoru Kohgo, et al.. (2006). Creation of Low Toxic Reverse-transcriptase Inhibitory Nucleosides that Prevent the Emergence of Drug-resistant HIV Variants. Journal of Synthetic Organic Chemistry Japan. 64(7). 716–723. 8 indexed citations

14.

Kohgo, Satoru, Kohei Yamada, Kenji Kitano, et al.. (2004). Design, Efficient Synthesis, and Anti‐HIV Activity of 4′‐C‐Cyano‐ and 4′‐C‐Ethynyl‐2′‐deoxy Purine Nucleosides. Nucleosides Nucleotides & Nucleic Acids. 23(4). 671–690. 39 indexed citations

15.

Kohgo, Satoru, Kohei Yamada, Kenji Kitano, et al.. (2003). Synthesis of 4′-C-Ethynyl and 4′-C-Cyano Purine Nucleosides from Natural Nucleosides and Their Anti-HIV Activity. Nucleosides Nucleotides & Nucleic Acids. 22(5-8). 887–889. 3 indexed citations

16.

Kohgo, Satoru, Eiichi Kodama, Shirô Shigeta, et al.. (1999). Synthesis of 4'-substituted nucleosides and their biological evaluation. Nucleic Acids Symposium Series. 42(1). 127–128. 6 indexed citations

17.

Yamaguchi, Ryohei, et al.. (1999). Synthesis of 4′-C-Ethynyl-β-D-ribo-pentofuranosyl Pyrimidines. Bioscience Biotechnology and Biochemistry. 63(4). 736–742. 8 indexed citations

18.

Kohgo, Satoru, et al.. (1999). Synthesis of 4′-C-Ethynyl-β-D-arabino- and 4′-C-Ethynyl-2′-deoxy-β-D-ribo- pentofuranosyl Pyrimidines, and Their Biological Evaluation. Bioscience Biotechnology and Biochemistry. 63(6). 1146–1149. 10 indexed citations

19.

Kohgo, Satoru, et al.. (1997). Chiral Discrimination of 2′-Deoxy-l-cytidine andl-Nucleotides by Mouse Deoxycytidine Kinase: Low Stereospecificities for Substrates and Effectors. Biochemical and Biophysical Research Communications. 239(1). 329–333. 9 indexed citations

20.

Yamaguchi, Tohru, et al.. (1997). Synthesis and evaluation of oligodeoxyribonucleotides containing an aryl(trifluoromethyl)diazirine moiety as the cross-linking probe: photoaffinity labeling of mammalian DNA polymerase . Nucleic Acids Research. 25(12). 2352–2358. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact